Concord Biotech Achieves 10.77% Increase in June 2024 Net Sales
Monday, 12 August 2024, 23:29
Concord Biotech's Standalone Financial Report
Concord Biotech has released its standalone quarterly financial figures for June 2024, showcasing a significant advancement.
Key Highlights
- Net Sales: Rs 215.80 crore
- Year-on-Year Growth: 10.77%
- Previous Year Sales: Rs 194.83 crore
- Quarterly Net Profit: Rs 58.24 crore
This growth demonstrates the company's strong market performance and financial health.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.